Business Context and Reporting Period
This Form 8-K was filed by Akerna Corp. on September 20, 2021, reporting an agreement entered into on September 13, 2021. The provided metadata identifies American Bitcoin Corp., but the filing names Akerna Corp. as the registrant. Akerna agreed to acquire 365 Cannabis, the business name of The Nav People, Inc.
Transaction and Key Financial Terms
- Akerna agreed to purchase all outstanding securities of 365 Cannabis for an initial purchase price of $17 million.
- At least $4 million of the purchase price is to be paid in cash, with the remainder potentially payable in Akerna common stock.
- The stock component is priced at $3.3636 per share, based on Akerna’s 20-day volume-weighted average price at signing.
- The purchase price remains subject to adjustments, including working capital, cash and cash equivalents, indebtedness, transaction expenses, employee compensation increases, lender payoffs, and cash and share escrows.
- A potential 12-month earn-out is based on recurring revenue and is capped at $8 million. Akerna may pay the earn-out in cash or common stock, subject to Nasdaq issuance rules.
Material Changes and Transaction Status
The filing announces a material definitive agreement; it does not report operating results, revenue, profit, cash flow, margins, debt balances, or liquidity metrics for Akerna or 365 Cannabis. Closing was subject to customary conditions, including accurate representations and warranties, covenant performance, no material adverse effect, and required consents.
Akerna expected the transaction to close on or around October 1, 2021. The agreement could be terminated if it did not close by November 12, 2021, subject to specified termination rights and cure periods. The filing does not confirm that closing occurred.
Management Commentary, Risks, and Unusual Items
- The transaction involves execution, financing, valuation, integration, and closing-condition risks.
- The final consideration could differ materially from $17 million because of contractual purchase-price adjustments and the potential earn-out.
- Any stock consideration or stock-funded earn-out could dilute existing Akerna shareholders and may require stockholder approval if Nasdaq rules are implicated.
- Jeff Kiehn agreed to a two-year North America non-solicitation and non-compete covenant.
- The agreement includes post-closing indemnification obligations for both the sellers and Akerna.
- The filing does not provide financial statements or standalone operating metrics for 365 Cannabis.
Investor Verification Priorities
- Verify the correct issuer: the filing identifies Akerna Corp., not American Bitcoin Corp.
- Confirm whether the acquisition closed, the actual cash and stock consideration paid, and all purchase-price adjustments.
- Review subsequent filings for the acquisition’s accounting treatment, goodwill, debt, dilution, and integration results.
- Assess 365 Cannabis recurring revenue and the potential earn-out obligation.
- Review the complete Stock Purchase Agreement filed as Exhibit 10.1 for detailed conditions, escrow terms, indemnities, and termination provisions.